Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an announcement.
Integral Diagnostics Limited announced the release of 876,068 fully paid ordinary shares from voluntary escrow on November 1, 2025. This release will not affect the company’s issued capital, indicating a stable financial position and potentially reassuring stakeholders about the company’s operational consistency.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services in Australia and New Zealand, employing top radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model focused on quality patient care, service, and access.
Average Trading Volume: 1,146,193
Technical Sentiment Signal: Hold
Current Market Cap: A$965.9M
See more data about IDX stock on TipRanks’ Stock Analysis page.